An Open-label, Three-treatment, Three-period, One-sequence, Crossover Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Fimasartan; Ketoconazole; Rifampicin
- Indications Hypertension; Tuberculosis
- Focus Pharmacokinetics
- 09 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 21 Jul 2009 New trial record